National Health Investors (NYSE:NHI) Issues FY 2022 Earnings Guidance

National Health Investors (NYSE:NHIGet Rating) issued an update on its FY 2022 earnings guidance on Monday morning. The company provided EPS guidance of $4.32-$4.42 for the period. The company issued revenue guidance of -.

Shares of National Health Investors stock traded down $0.39 during trading on Wednesday, hitting $56.84. 3,035 shares of the company’s stock traded hands, compared to its average volume of 281,326. The company has a debt-to-equity ratio of 0.84, a current ratio of 23.40 and a quick ratio of 23.40. National Health Investors has a 1 year low of $50.22 and a 1 year high of $69.23. The stock has a market capitalization of $2.61 billion, a P/E ratio of 31.08 and a beta of 0.97. The business has a 50-day simple moving average of $55.87 and a 200-day simple moving average of $55.97.

National Health Investors (NYSE:NHIGet Rating) last announced its earnings results on Monday, May 9th. The real estate investment trust reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.63 by ($0.45). The firm had revenue of $71.33 million during the quarter, compared to analysts’ expectations of $73.06 million. National Health Investors had a return on equity of 5.55% and a net margin of 29.35%. The company’s revenue for the quarter was down 11.8% on a year-over-year basis. During the same period in the previous year, the business posted $1.24 earnings per share. On average, equities analysts predict that National Health Investors will post 4.45 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, August 5th. Shareholders of record on Thursday, June 30th will be given a $0.90 dividend. The ex-dividend date of this dividend is Wednesday, June 29th. This represents a $3.60 annualized dividend and a yield of 6.33%. National Health Investors’s payout ratio is 195.65%.

Several brokerages have issued reports on NHI. BMO Capital Markets dropped their target price on National Health Investors from $63.00 to $61.00 and set an outperform rating on the stock in a research report on Tuesday, April 19th. StockNews.com started coverage on National Health Investors in a research report on Thursday, March 31st. They set a hold rating on the stock. Zacks Investment Research raised National Health Investors from a strong sell rating to a hold rating in a research report on Friday, May 13th. Finally, Credit Suisse Group started coverage on National Health Investors in a research report on Tuesday, February 1st. They set an underperform rating and a $51.00 price objective on the stock. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, National Health Investors presently has an average rating of Hold and an average price target of $62.00.

Institutional investors and hedge funds have recently modified their holdings of the stock. Schonfeld Strategic Advisors LLC increased its stake in National Health Investors by 24.3% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 9,326 shares of the real estate investment trust’s stock worth $536,000 after acquiring an additional 1,826 shares during the last quarter. Hsbc Holdings PLC increased its stake in National Health Investors by 27.8% in the 1st quarter. Hsbc Holdings PLC now owns 9,014 shares of the real estate investment trust’s stock worth $533,000 after acquiring an additional 1,962 shares during the last quarter. LPL Financial LLC increased its stake in National Health Investors by 23.9% in the 4th quarter. LPL Financial LLC now owns 8,242 shares of the real estate investment trust’s stock worth $474,000 after acquiring an additional 1,589 shares during the last quarter. Meiji Yasuda Asset Management Co Ltd. bought a new stake in National Health Investors in the 1st quarter worth approximately $453,000. Finally, Nelson Van Denburg & Campbell Wealth Management Group LLC bought a new position in shares of National Health Investors during the 1st quarter valued at approximately $447,000. 63.53% of the stock is currently owned by institutional investors.

About National Health Investors (Get Rating)

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Stories

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.